XML 50 R13.htm IDEA: XBRL DOCUMENT v2.4.0.8
Note 5 - Benefit Plans
9 Months Ended
Sep. 30, 2013
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Disclosure of Compensation Related Costs, Share-based Payments [Text Block]

Note 5:   Benefit Plans   


The Company has stock-based employee compensation plans, which are described in the Company’s 2012 Annual Report on Form 10-K.


The table below summarizes transactions under the Company’s stock option plans for the nine months ended September 30, 2013:


   

Number of shares

         
   

Incentive Stock

Option

   

Non-

Incentive

Stock Option

   

Weighted

Average

Exercise Price

 
                         

Balance outstanding as of January 1, 2013

    174,500       167,000     $ 16.38  

Granted

    -       -       -  

Exercised

    (1,800 )     -       5.23  

Forfeited

    (2,200 )     (44,500 )     16.86  

Balance outstanding as of September 30, 2013

    170,500       122,500       16.42  

Options exercisable as of September 30, 2013

    149,500       104,250       18.15  

Stock-based compensation expense, consisting of stock options and restricted stock awards, recognized for the three months ended September 30, 2013 and 2012 was $31,923 and $40,056, respectively. Stock-based compensation expense recognized for the nine months ended September 30, 2013 and 2012 was $219,199 and $219,732, respectively. As of September 30, 2013, there was $99,815 of unrecognized compensation expense related to nonvested stock options and restricted stock awards, which will be recognized over the remaining vesting period.


In January 2013 and 2012, the Company granted restricted stock to directors pursuant to the 2010 Equity Plan that was fully vested as of the date of the grant and thus, expensed in full on the date of the grant. The amount expensed was $116,032 and $110,009 for 2013 and 2012, respectively, which represents 16,576 shares of common stock at a market price of $7.00 at the date of grant in 2013 and 18,520 shares of common stock at a market price of $5.94 at the date of grant in 2012.